Injectable Influenza Vaccine
Closed Pre-Solicitation Posted
A newer solicitation was posted. See the latest solicitation from .
- Solicitation number
- SPE2DP25R0005
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
-
- Yu Chen yu.chen@dla.mil (445) 737-7606
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is seeking contractors to supply Injectable Influenza Vaccine for the 2026-2027 flu season through an indefinite quantity contract. The procurement requires approximately 3.08 million doses delivered in prefilled syringes, with vaccines that must be FDA-approved for multiple age categories including individuals 65 years and older, 18 years and older, 3 years and older, and pediatric groups aged 6 months to 35 months. Successful contractors must possess FDA approval and supply vaccines that are CDC Advisory Committee on Immunization Practices (ACIP) recommended, with the specific formula to be determined by the FDA Vaccines and Related Biological Products Advisory Committee. The solicitation is projected for release in September 2025, with a response deadline of August 21, 2025, though DLA reserves the right to adjust this timeline. Interested parties can contact Meghan Smink at 445-737-6160 or Meghan.Smink@dla.mil for questions and should monitor the DLA Bid Board System and SAM.gov for updates.
This procurement does not utilize any set-aside designations and will operate under an indefinite quantity contract structure with specific volume parameters. The contract guarantees a minimum quantity of 75% of the annual estimate (approximately 2.31 million doses) and establishes a maximum ceiling of 150% of the annual estimate (approximately 4.62 million doses). All vaccine deliveries must be made to the Defense Depot in New Cumberland, Pennsylvania, following a staggered delivery schedule with 40% due by August 14, 2026, 25% by August 28, 2026, 25% by September 11, 2026, and the remaining 10% by September 25, 2026. The contract falls under NAICS code 325414 for Biological Product Manufacturing and PSC code 6505 for Drugs and Biologicals. National Stock Numbers will be established upon contract award, and alternative delivery schedules may be considered beyond the preferred timeline.
Notice text
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Influenza Vaccine for the 2026-2027 flu season. Approximately 3.08 million doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in prefilled syringes presentation. The vaccine shall be FDA-approved for the following age categories: for immunizing individuals 65 years and older, for immunizing individuals 18 years and older, for immunizing individuals 3 years and older, and for immunizing 6 months to 35 months (pediatric group).
The formula for the 2026-2027 season shall be determined by the U.S. Food & Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval, and the vaccine must be U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended. National Stock Numbers shall be established at the time of award.
An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate.
All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 40% of the requirement by August 14, 2026, 25% by August 28, 2026, 25% by September 11, 2026, and the residual 10% by September 25, 2026. This delivery schedule is the preferred delivery schedule. Other delivery schedules may be considered.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Meghan Smink (445-737-6160) (Meghan.Smink@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is September of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Injectable Influenza Vaccine | Solicitation | |
| Injectable Influenza Vaccine | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity